<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR77">
 <label>77.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhu</surname>
    <given-names>HH</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>DP</given-names>
   </name>
   <name>
    <surname>Du</surname>
    <given-names>X</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial</article-title>
  <source>Lancet Oncol</source>
  <year>2018</year>
  <volume>19</volume>
  <fpage>871</fpage>
  <lpage>9</lpage>
  <pub-id pub-id-type="doi">10.1016/S1470-2045(18)30295-X</pub-id>
  <?supplied-pmid 29884593?>
  <pub-id pub-id-type="pmid">29884593</pub-id>
 </element-citation>
</ref>
